| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Lantheus Holdings, Inc | $4.8b | $80.56 | -1.1% | 486.2K | |
| Immunome, Inc. | $2.2b | $21.64 | -3.6% | 1.1M | |
| AbCellera Biologics Inc. Common Shares | $1.0b | $3.54 | +3.1% | 2.4M | |
| Aktis Oncology, Inc. Common stock | $0.9b | $16.89 | -4.4% | 263.9K | |
| Alpha Tau Medical Ltd. Ordinary Shares | $0.6b | $7.33 | -0.3% | 126.2K | |
| Crescent Biopharma, Inc. Common Stock | $0.5b | $18.27 | -4.3% | 154.7K | |
| Perspective Therapeutics, Inc. | $436.4m | $4.47 | -0.4% | 498.4K | |
| PLUS THERAPEUTICS, Inc. Common Stock | $36.8m | $4.75 | +21.2% | 1.3M | |
| Actinium Pharmaceuticals, Inc | $30.9m | $1.08 | -5.3% | 74.4K | |
| American Shared Hospital Services | $11.9m | $1.35 | +1.5% | 14.4K | |
| iTonic Holdings Ltd Class A Ordinary Shares | $7.0m | $0.30 | +1.7% | 73.6K |